ANAVEX LIFE SCIENCES CORP. Operating Income
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Operating Income of $6.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for the quarter ending 2026-06-30 was $6.74M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for the quarter ending 2026-03-31 was -$6.48M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for the quarter ending 2025-12-31 was -$6.78M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for the quarter ending 2025-09-30 was -$10.84M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for fiscal 2025 was -$51.41M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for fiscal 2024 was -$52.88M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for fiscal 2023 was -$55.76M.
- ANAVEX LIFE SCIENCES CORP. operating income (loss) for fiscal 2022 was -$50.99M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 89 month | Operating Income (Loss) 92 month | Operating Income (Loss) 95 month | Operating Income (Loss) 98 month | Operating Income (Loss) 101 month | Operating Income (Loss) 104 month | Operating Income (Loss) 107 month | Operating Income (Loss) 110 month | Operating Income (Loss) 113 month | Operating Income (Loss) 116 month | Operating Income (Loss) 119 month | Operating Income (Loss) 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.74M 10-Q · filed 2026-08-28 | $253.00K derived: sum of 2 quarters · filed 2026-08-28 | -$6.53M 10-Q · filed 2026-08-28 | -$17.37M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2026-03-31 | -$6.48M 10-Q · filed 2026-08-28 | -$13.27M 10-Q · filed 2026-08-28 | -$24.11M derived: sum of 3 quarters · filed 2026-08-28 | -$38.57M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-12-31 | -$6.78M 10-Q · filed 2026-02-09 | -$17.63M derived: sum of 2 quarters · filed 2026-08-28 | -$32.09M derived: sum of 3 quarters · filed 2026-08-28 | -$44.60M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-09-30 | -$10.84M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$25.30M derived: sum of 2 quarters · filed 2026-08-28 | -$37.82M derived: sum of 3 quarters · filed 2026-08-28 | -$51.41M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2025-06-30 | -$14.46M 10-Q · filed 2026-08-28 | -$26.97M derived: sum of 2 quarters · filed 2026-08-28 | -$40.56M 10-Q · filed 2026-08-28 | -$54.84M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2025-03-31 | -$12.51M 10-Q · filed 2026-08-28 | -$26.11M 10-Q · filed 2026-08-28 | -$40.38M derived: sum of 3 quarters · filed 2026-08-28 | -$54.98M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-12-31 | -$13.59M 10-Q · filed 2026-02-09 | -$27.86M derived: sum of 2 quarters · filed 2026-08-28 | -$42.47M derived: sum of 3 quarters · filed 2026-08-28 | -$55.09M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||||
| 2024-09-30 | -$14.27M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$28.87M derived: sum of 2 quarters · filed 2026-08-28 | -$41.50M derived: sum of 3 quarters · filed 2026-08-28 | -$52.88M 10-K/A · filed 2026-08-28 | ||||||||||||||||
| 2024-06-30 | -$14.60M 10-Q · filed 2025-08-12 | -$14.73M 10-Q · filed 2024-08-06 | -$27.23M derived: sum of 2 quarters · filed 2025-08-12 | -$38.61M 10-Q · filed 2025-08-12 | -$38.54M 10-Q · filed 2024-08-06 | -$51.26M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||
| 2024-03-31 | -$12.62M 10-Q · filed 2025-05-13 | -$12.52M 10-Q · filed 2024-05-09 | -$24.00M 10-Q · filed 2025-05-13 | -$23.81M 10-Q · filed 2024-05-09 | -$36.66M derived: sum of 3 quarters · filed 2026-08-28 | -$50.19M derived: sum of 4 quarters · filed 2026-08-28 | ||||||||||||||
| 2023-12-31 | -$11.38M 10-Q · filed 2025-02-12 | -$11.29M 10-Q · filed 2024-02-07 | -$24.04M derived: sum of 2 quarters · filed 2026-08-28 | -$37.57M derived: sum of 3 quarters · filed 2026-08-28 | -$51.76M derived: sum of 4 quarters · filed 2026-08-28 | |||||||||||||||
| 2023-09-30 | -$12.66M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$26.19M derived: sum of 2 quarters · filed 2026-08-28 | -$40.38M derived: sum of 3 quarters · filed 2026-08-28 | -$55.76M 10-K/A · filed 2026-08-28 | -$55.76M 10-K · filed 2023-11-27 | |||||||||||||||
| 2023-06-30 | -$13.53M 10-Q · filed 2024-08-06 | -$13.53M 10-Q · filed 2023-08-08 | -$27.72M derived: sum of 2 quarters · filed 2024-08-06 | -$43.10M 10-Q · filed 2024-08-06 | -$43.10M 10-Q · filed 2023-08-08 | -$58.39M derived: sum of 4 quarters · filed 2024-08-06 | ||||||||||||||
| 2023-03-31 | -$14.19M 10-Q · filed 2024-05-09 | -$14.19M 10-Q · filed 2023-05-09 | -$29.57M 10-Q · filed 2024-05-09 | -$29.57M 10-Q · filed 2023-05-09 | -$44.86M derived: sum of 3 quarters · filed 2024-05-09 | -$57.32M derived: sum of 4 quarters · filed 2024-05-09 | ||||||||||||||
| 2022-12-31 | -$15.38M 10-Q · filed 2024-02-07 | -$15.38M 10-Q · filed 2023-02-07 | -$30.67M derived: sum of 2 quarters · filed 2024-02-07 | -$43.13M derived: sum of 3 quarters · filed 2024-02-07 | -$54.65M derived: sum of 4 quarters · filed 2024-02-07 | |||||||||||||||
| 2022-09-30 | -$15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | -$27.74M derived: sum of 2 quarters · filed 2023-11-27 | -$39.26M derived: sum of 3 quarters · filed 2023-11-27 | -$50.99M 10-K · filed 2023-11-27 | -$50.99M 10-K · filed 2022-11-28 | |||||||||||||||
| 2022-06-30 | -$12.46M 10-Q · filed 2023-08-08 | -$23.98M derived: sum of 2 quarters · filed 2023-08-08 | -$35.70M 10-Q · filed 2023-08-08 | |||||||||||||||||
| 2022-03-31 | -$11.52M 10-Q · filed 2023-05-09 | -$23.24M 10-Q · filed 2023-05-09 | ||||||||||||||||||
| 2021-12-31 | -$11.72M 10-Q · filed 2023-02-07 | |||||||||||||||||||
| 2021-09-30 | -$42.00M 10-K · filed 2023-11-27 | -$42.00M 10-K · filed 2022-11-28 | ||||||||||||||||||
| 2020-09-30 | -$31.09M 10-K · filed 2022-11-28 | |||||||||||||||||||
| 2015-06-30 | -$1.51M 10-Q · filed 2015-08-14 | -$2.37M derived: sum of 2 quarters · filed 2015-08-14 | -$3.14M 10-Q · filed 2015-08-14 | -$3.78M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2015-03-31 | -$858.34K 10-Q · filed 2015-05-14 | -$1.63M 10-Q · filed 2015-05-14 | -$2.27M derived: sum of 3 quarters · filed 2015-05-14 | -$3.27M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-12-31 | -$770.68K 10-Q · filed 2015-02-17 | -$1.41M derived: sum of 2 quarters · filed 2015-02-17 | -$2.41M derived: sum of 3 quarters · filed 2015-08-14 | -$3.43M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-09-30 | -$639.37K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | -$1.64M derived: sum of 2 quarters · filed 2015-08-14 | -$2.66M derived: sum of 3 quarters · filed 2015-08-14 | -$2.97M 10-K · filed 2014-12-29 | ||||||||||||||||
| 2014-06-30 | -$998.83K 10-Q · filed 2015-08-14 | -$2.02M derived: sum of 2 quarters · filed 2015-08-14 | -$2.33M 10-Q · filed 2015-08-14 | -$3.80M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-03-31 | -$1.02M 10-Q · filed 2015-05-14 | -$1.33M 10-Q · filed 2015-05-14 | -$2.80M derived: sum of 3 quarters · filed 2015-05-14 | -$2.93M derived: sum of 4 quarters · filed 2015-05-14 | -$31.35M 10-Q/A · filed 2014-05-30 | |||||||||||||||
| 2013-12-31 | -$309.61K 10-Q · filed 2015-02-17 | -$1.78M derived: sum of 2 quarters · filed 2015-02-17 | -$1.90M derived: sum of 3 quarters · filed 2015-02-17 | -$2.03M derived: sum of 4 quarters · filed 2015-02-17 | -$30.33M 10-Q · filed 2014-02-14 | |||||||||||||||
| 2013-09-30 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | -$1.59M derived: sum of 2 quarters · filed 2014-12-29 | -$1.72M derived: sum of 3 quarters · filed 2014-12-29 | -$2.14M 10-K · filed 2014-12-29 | -$30.02M 10-K · filed 2013-12-30 | |||||||||||||||
| 2013-06-30 | -$125.98K 10-Q · filed 2014-08-13 | -$253.09K derived: sum of 2 quarters · filed 2014-08-13 | -$668.96K 10-Q · filed 2014-08-13 | -$1.31M derived: sum of 4 quarters · filed 2014-08-13 | -$28.55M 10-Q · filed 2013-08-14 | |||||||||||||||
| 2013-03-31 | -$127.11K 10-Q/A · filed 2014-05-30 | -$542.98K 10-Q/A · filed 2014-05-30 | -$1.19M derived: sum of 3 quarters · filed 2014-05-30 | -$1.88M derived: sum of 4 quarters · filed 2014-05-30 | -$28.43M 10-Q · filed 2013-05-17 | |||||||||||||||
| 2012-12-31 | -$415.87K 10-Q · filed 2014-02-14 | -$1.06M derived: sum of 2 quarters · filed 2014-02-14 | -$1.76M derived: sum of 3 quarters · filed 2014-02-14 | -$2.55M derived: sum of 4 quarters · filed 2014-02-14 | -$28.30M 10-Q · filed 2013-02-14 | |||||||||||||||
| 2012-09-30 | -$642.51K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | -$1.34M derived: sum of 2 quarters · filed 2013-12-30 | -$2.14M derived: sum of 3 quarters · filed 2013-12-30 | -$4.32M 10-K · filed 2013-12-30 | -$27.88M 10-K · filed 2012-12-31 | |||||||||||||||
| 2012-06-30 | -$697.91K 10-Q · filed 2013-08-14 | -$1.49M derived: sum of 2 quarters · filed 2013-08-14 | -$3.68M 10-Q · filed 2013-08-14 | -$4.91M derived: sum of 4 quarters · filed 2013-08-14 | -$27.24M 10-Q · filed 2012-08-17 | |||||||||||||||
| 2012-03-31 | -$795.61K 10-Q · filed 2013-05-17 | -$2.98M 10-Q · filed 2013-05-17 | -$4.21M derived: sum of 3 quarters · filed 2013-05-17 | -$5.85M derived: sum of 4 quarters · filed 2013-05-17 | -$26.54M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | -$2.19M 10-Q · filed 2013-02-14 | -$3.42M derived: sum of 2 quarters · filed 2013-02-14 | -$5.05M derived: sum of 3 quarters · filed 2013-02-14 | -$7.00M derived: sum of 4 quarters · filed 2013-02-14 | -$25.75M 10-Q · filed 2012-02-14 | |||||||||||||||
| 2011-09-30 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | -$2.86M derived: sum of 2 quarters · filed 2012-12-31 | -$4.81M derived: sum of 3 quarters · filed 2012-12-31 | -$6.18M 10-K · filed 2012-12-31 | -$23.56M 10-K · filed 2011-12-22 | |||||||||||||||
| 2011-06-30 | -$1.64M 10-Q · filed 2012-08-17 | -$3.58M derived: sum of 2 quarters · filed 2012-08-17 | -$4.95M 10-Q · filed 2012-08-17 | -$6.92M derived: sum of 4 quarters · filed 2012-08-17 | -$22.34M 10-Q · filed 2011-08-12 | |||||||||||||||
| 2011-03-31 | -$1.95M 10-Q · filed 2012-05-15 | -$3.32M 10-Q · filed 2012-05-15 | -$5.28M derived: sum of 3 quarters · filed 2012-05-15 | -$6.58M derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | -$1.37M 10-Q · filed 2012-02-14 | -$3.33M derived: sum of 2 quarters · filed 2012-02-14 | -$4.64M derived: sum of 3 quarters · filed 2012-02-14 | |||||||||||||||||
| 2010-09-30 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | -$3.27M derived: sum of 2 quarters · filed 2011-12-22 | -$5.65M 10-K · filed 2011-12-22 | |||||||||||||||||
| 2010-06-30 | -$1.30M 10-Q · filed 2011-08-12 | -$3.68M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |